Kura Oncology, Inc. (KURA)

USD 9.12

(-6.37%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - - - -
Cost of Revenue 849 Thousand 759 Thousand 558 Thousand 194 Thousand - 10 Thousand
Gross Profit -849 Thousand -759 Thousand -558 Thousand -194 Thousand - -10 Thousand
Operating Expenses 165.8 Million 139.86 Million 131.25 Million 91.89 Million 67.47 Million 62.88 Million
Selling, General and Administrative Expenses 50.56 Million 47.05 Million 46.53 Million 31.5 Million 19.65 Million 16.09 Million
Research and Development Expenses 115.23 Million 92.81 Million 84.72 Million 60.39 Million 47.82 Million 46.78 Million
Other Expenses - 4.02 Million 792 Thousand 2.27 Million 4.33 Million 2.43 Million
Cost and Expenses 165.8 Million 139.86 Million 131.25 Million 91.89 Million 67.47 Million 62.88 Million
Operating Income -165.8 Million -140.62 Million -131.81 Million -92.09 Million -67.47 Million -62.88 Million
Interest Expense 1.54 Million 229 Thousand 414 Thousand 578 Thousand 580 Thousand 970 Thousand
Income Tax Expense - 229 Thousand -558 Thousand -194 Thousand -10.00 3.4 Million
Earnings before Tax -152.63 Million -135.84 Million -130.46 Million -89.62 Million -63.14 Million -60.44 Million
Net Income -152.63 Million -136.06 Million -129.9 Million -89.43 Million -63.14 Million -60.44 Million
Earnings Per Share Basic -2.08 -2.03 -1.96 -1.68 -1.51 -1.72
Earnings Per Share Diluted -2.08 -2.03 -1.96 -1.68 -1.51 -1.72
Weighted Average Shares Outstanding 73.22 Million 66.98 Million 66.35 Million 53.07 Million 41.94 Million 35.19 Million
Weighted Average Shares Outstanding (Diluted) 73.22 Million 66.98 Million 66.35 Million 53.07 Million 41.94 Million 35.19 Million
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA -164.95 Million -139.1 Million -129.7 Million -91.7 Million -67.47 Million -62.87 Million
Earnings Before Tax Margin - - - - - -

Income Statement Charts